Hinge Health Inc. HNGE
95.57
3.59
3.90%
as of 25 Sep
- Market cap
- $7.4B
- P/E
- 70.8×
Follow HNGE
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+6 more TTM periods Free account |
0.00% | 345.72% | 316.76% | 41.44% | |
| (118.50%) | (113.89%) | (140.34%) | 14.12% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(147.03%) | (233.03%) | (373.47%) | 61.47% | |
Average Days of Receivables |
61.17 | 41.02 | 64.90 | 63.58 | |
Free Cash Flow per Share |
1.79 | 3.03 | 2.58 | 3.60 | |
Free Cash Flow |
141.48 | 165.38 | 202.76 | 283.92 | |
Capital Expenditures |
(4.40) | (6.06) | (6.84) | (6.86) | |
Piotroski F-Score |
1.00 | 1.00 | 1.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
21.20% | 31.60% | 49.02% | 39.63% | |
Accounts Receivable Turnover |
0.00 | 10.44 | 8.21 | 6.41 | |
Accounts Payable Turnover |
0.00 | 2.48 | 2.55 | 2.34 | |
Inventory Turnover |
0.00 | 8.27 | 9.91 | 7.26 | |
Average Days of Payables |
169.89 | 174.91 | 204.31 | 198.49 | |
Days of Inventory on Hand |
44.11 | 47.70 | 41.66 | 54.82 | |
Tax Rate |
0.00 | 0.00 | 0.00 | (0.02) | |
Research and Development Expense of Revenue |
69.37% | 62.62% | 58.02% | 17.93% | |
Selling, General and Administrative Expense of Revenue |
120.09% | 109.97% | 104.39% | 53.56% | |
Share Based Compensation of Revenue |
120.90% | 109.38% | 101.29% | 11.50% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.32) | (0.40) | (0.41) | 2.71 | |
Depreciation/Fixed assets |
5.64 | 4.97 | 5.21 | 5.30 | |
Capex/Depreciation |
(0.09) | (0.12) | (0.12) | (0.10) | |
Revenue per Share |
6.57 | 10.77 | 8.22 | 9.12 | |
Operating CF per Share |
1.85 | 3.14 | 2.67 | 3.68 | |
Capex per Share |
(0.06) | (0.11) | (0.09) | (0.09) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(88.09%) | (72.14%) | (79.12%) | 14.91% |
Columns are period end dates